Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of trastuzumab monotherapy in pretreated metastatic or locally advanced HER2-positive gastric cancer
2005-001220-37Phase 2Completed
- Sponsor
- Roche
- Start
- Mar 2005
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trastuzumab in gastric cancer (GC), sponsored by Roche. Primary endpoint: Objective response rate. Started Mar 2005; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on 2005-001220-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001220-37.